Literature DB >> 10564693

Thalidomide--a revival story.

N Raje, K Anderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10564693     DOI： 10.1056/NEJM199911183412110

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  27 in total

1.  Generating hypotheses by discovering implicit associations in the literature: a case report of a search for new potential therapeutic uses for thalidomide.

Authors:  Marc Weeber; Rein Vos; Henny Klein; Lolkje T W De Jong-Van Den Berg; Alan R Aronson; Grietje Molema
Journal:  J Am Med Inform Assoc       Date:  2003-01-28       Impact factor: 4.497

Review 2.  Multiple myeloma.

Authors:  N Raje; K C Anderson
Journal:  Curr Treat Options Oncol       Date:  2000-04

3.  Do new therapeutic approaches (autotransplants, thalidomide, dexamethasone) improve the survival of patients with multiple myeloma followed in a rheumatology department?

Authors:  S El Mahou; M Attal; B Jamard; A Constantin; A Cantagrel; B Mazières; C Arnaud; M Laroche
Journal:  Clin Rheumatol       Date:  2005-11-23       Impact factor: 2.980

Review 4.  From nutraceuticals to pharmaceuticals to nanopharmaceuticals: a case study in angiogenesis modulation during oxidative stress.

Authors:  Shaker A Mousa; Dhruba J Bharali; Donald Armstrong
Journal:  Mol Biotechnol       Date:  2007-09       Impact factor: 2.695

5.  Combination therapy with thalidomide, incadronate, and dexamethasone for relapsed or refractory multiple myeloma.

Authors:  Naoya Ochiai; Noriko Yamada; Ryo Uchida; Shin-ichi Fuchida; Akira Okano; Mayumi Hatsuse; Masashi Okamoto; Eishi Ashihara; Chihiro Shimazaki
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

6.  Thalidomide induced nonspecific interstitial pneumonia in patient with relapsed multiple myeloma.

Authors:  Myung-Hee Kang; Ji-Hyun Ju; Hoon-Gu Kim; Jung Hun Kang; Kyung-Nyeo Jeon; Ho-Cheol Kim; Gyeong-Won Lee
Journal:  Korean J Intern Med       Date:  2010-11-27       Impact factor: 2.884

7.  Thalidomide and its analogues have distinct and opposing effects on TNF-alpha and TNFR2 during co-stimulation of both CD4(+) and CD8(+) T cells.

Authors:  J B Marriott; I A Clarke; K Dredge; G Muller; D Stirling; A G Dalgleish
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

Review 8.  Potential novel uses of thalidomide: focus on palliative care.

Authors:  V Peuckmann; M Fisch; E Bruera
Journal:  Drugs       Date:  2000-08       Impact factor: 9.546

9.  Effect of thalidomide and rosiglitazone on the prevention of diabetic retinopathy in streptozotocin-induced diabetic rats.

Authors:  A A Bosco; A C Lerario; R F Santos; B L Wajchenberg
Journal:  Diabetologia       Date:  2003-11-04       Impact factor: 10.122

10.  Latanoprost-induced changes in rat intraocular pressure: direct or indirect?

Authors:  Shahid Husain; Phillip W Yates; Craig E Crosson
Journal:  J Ocul Pharmacol Ther       Date:  2008-08       Impact factor: 2.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.